Get the Stockscreener App
4.02
2.90%
-0.12
After Hours:
4.02
Cytek Biosciences Inc stock is traded at $4.02, with a volume of 832.00K.
It is down -2.90% in the last 24 hours and up +10.44% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$4.14
Open:
$4.1
24h Volume:
832.00K
Relative Volume:
0.68
Market Cap:
$511.44M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-44.67
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
-3.37%
1M Performance:
+10.44%
6M Performance:
-10.47%
1Y Performance:
-29.97%
1-Day Range:
$3.945
$4.115
1-Week Range:
$3.945
$4.23
52-Week Range:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.02 | 526.71M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
Cytek Biosciences Inc Stock (CTKB) Latest News
Earnings visualization tools for Cytek Biosciences Inc.July 2025 Trends & Real-Time Market Sentiment Alerts - Newser
Cytek Biosciences Inc. stock trend forecastTrade Risk Assessment & Growth Focused Entry Point Reports - Newser
Will breakout in Cytek Biosciences Inc. lead to full recoveryBreakout Watch & Risk Adjusted Swing Trade Ideas - Newser
What’s the recovery path for long term holders of Cytek Biosciences Inc.2025 Market WrapUp & Precise Buy Zone Identification - Newser
Is Cytek Biosciences Inc. stock a good pick for beginners2025 Trade Ideas & Free Community Consensus Stock Picks - خودرو بانک
Is this a good reentry point in Cytek Biosciences Inc.Sell Signal & Capital Efficiency Focused Ideas - Newser
Is Cytek Biosciences Inc. a cyclical or defensive stock2025 Key Lessons & Growth Oriented Trading Recommendations - خودرو بانک
How sentiment analysis helps forecast Cytek Biosciences Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - Newser
How to forecast Cytek Biosciences Inc. trends using time seriesTrade Risk Assessment & Precise Entry and Exit Recommendations - Newser
Cytek Biosciences Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Cytek Biosciences Inc. currently under institutional pressure2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - خودرو بانک
Is Cytek Biosciences Inc. stock a buy or sellWeekly Loss Report & Low Volatility Stock Suggestions - خودرو بانک
Identifying reversal signals in Cytek Biosciences Inc.July 2025 Sentiment & Accurate Technical Buy Alerts - Newser
Analyzing recovery setups for Cytek Biosciences Inc. investorsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Custom strategy builders for tracking Cytek Biosciences Inc.New Guidance & Low Risk Entry Point Tips - Newser
Cytek Biosciences Inc. stock prediction for this weekWeekly Gains Report & Reliable Intraday Trade Plans - Newser
Cytek Biosciences Inc. stock volume spike explainedInflation Watch & Technical Pattern Based Buy Signals - Newser
Strategies to average down on Cytek Biosciences Inc.2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - Newser
Key metrics from Cytek Biosciences Inc.’s quarterly dataWeekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
Applying Wyckoff theory to Cytek Biosciences Inc. stockJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
Price action breakdown for Cytek Biosciences Inc.July 2025 Momentum & Community Consensus Picks - Newser
Does Cytek Biosciences Inc. qualify in momentum factor screeningJuly 2025 Movers & Daily Risk Controlled Trade Plans - Newser
Advanced analytics toolkit walkthrough for Cytek Biosciences Inc.July 2025 Catalysts & Detailed Earnings Play Strategies - Newser
Can Cytek Biosciences Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - kangso.co.kr
How to build a dashboard for Cytek Biosciences Inc. stock2025 Institutional Moves & Weekly Breakout Stock Alerts - Newser
Can you recover from losses in Cytek Biosciences Inc.Risk Management & Daily Growth Stock Tips - Newser
How to interpret RSI for Cytek Biosciences Inc. stockJuly 2025 Snapshot & Daily Profit Focused Screening - Newser
Relative strength of Cytek Biosciences Inc. in sector analysis2025 Sector Review & Risk Adjusted Buy/Sell Alerts - Newser
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):